GEN - Genetic Engineering and Biotechnology News…
Information about GEN - Genetic Engineering and Biotechnology News…Where is GEN - Genetic Engineering and Biotechnology News… located?GEN - Genetic Engineering and Biotechnology News…'s Website
Factuality
How credible is the news from GEN - Genetic Engineering and Biotechnology News…?Learn more about Factuality Ratings.
Media Bias Ratings
Does GEN - Genetic Engineering and Biotechnology News… lean left or right?
Learn more about Media Bias Ratings.
Top GEN - Genetic Engineering and Biotechnology News… News
Cell and Gene Therapy: Unified Digital Solutions for R&D
VaccinationsShingles, also known as herpes zoster, is associated with an almost 30% higher long-term risk of a major cardiovascular event. Shingles is caused by the varicella zoster virus, the same virus that causes chickenpox. Approximately one in three individuals will develop shingles in their lifetime.See the Story
Stroke and Heart Attack Risk Rises after Shingles Infection
PASTE Expands CRISPR Toolbox by Inserting Large Pieces of DNA
Latest News Stories
BusinessEli Lilly to buy gene therapy company Akouos for $487 million. J&J results beat estimates on cancer drug strength. Bill & Melinda Gates Foundation pledges $1.2 billion to eradicate polio. U.S. nears record poultry deaths from bird flu; virus type complicates fight.See the Story
Eli Lilly to buy genetic medicine developer Akouos for $487 million
80% Center coverage: 5 sources
US & Canada · Los AngelesThe protein, called SHMOOSE, is a tiny microprotein encoded by a newly discovered gene within the cell's energy-producing mitochondria. A mutation within this gene partially inactivates the microprotein and is associated with a 20-50 % higher risk for Alzheimer's disease. Nearly a quarter of people of European ancestry have the mutated version of the protein, according to the researchers.See the Story
Scientists identify mutated protein linked to Alzheimer’s disease risk
64% Center coverage: 11 sources
FDAVerve Therapeutics says its experimental gene-editing treatment for a common form of heart disease was placed on clinical hold by the FDA. The Cambridge, Mass.-based biotech had submitted a request to the FDA in October to allow participants in the U.S. to receive the CRISPR-based treatment.See the Story
FDA places clinical hold on Verve Therapeutics gene-editing treatment
100% Center coverage: 1 sources
MedicalNoninvasive brain ultrasound treatment represents a promising alternative to other brain stimulation modalities and pharmaceutical drugs; however, testing it can be challenging due to a lack of preclinical systems for chronic stimulation in awake animals. As described in research published in Advanced Science, investigators recently developed a system to deliver ultrasound stimulation to the brain in awake, naturally behaving mice.See the Story
Researchers develop system to test brain ultrasound treatments in mice
100% Center coverage: 1 sources
Artificial IntelligenceTurbine is developing a cell behavior simulation platform to identify beneficial oncology treatments. Turbine's philosophy is that a cell in a patient is dissimilar to a model system perturbed by a CRISPR or chemical screen. A lot of ideas from in vitro models are often not true in patients, the company says.See the Story
